HOME >> MEDICINE >> NEWS
Landmark discovery of a Kaposi's sarcoma-associated herpesvirus receptor

Researchers at the National Institute of Allergy and Infectious Disease (NIAID), a component of the National Institutes of Health (NIH), have identified a critical human cell surface molecule involved in infection by Kaposi's sarcoma herpesvirus (KSHV), the virus that causes Kaposi's sarcoma and certain forms of lymphoma. Kaposi's sarcoma is a major cancer associated with HIV/AIDS, and it typically manifests as multiple purple-hued skin lesions.

In the March 31, 2006 issue of Science, NIAID research fellow Johnan Kaleeba, Ph.D. and senior investigator Edward A. Berger; Ph.D., describe how the molecule xCT is a major gateway that KSHV uses to enter human cells. The molecule may also play a role in the development of Kaposi's sarcoma and other syndromes associated with the virus.

The natural function of xCT in the body is to transport molecules necessary for protecting against stress into cells. When cells are stressed, they express more xCT on their surfaces. Of note, this sort of stress can be caused by KSHV itself. This suggests that the virus may facilitate its own infectivity and dissemination in the body by inducing a physiological state that results in increased numbers of its own receptor.

"The advancement of knowledge achieved in this study highlights the outstanding intramural research that takes place here on the NIH campus," says Elias A. Zerhouni, M.D., NIH director.

"Understanding the mechanisms of cell entry of Kaposi's sarcoma herpesvirus is a landmark achievement in and of itself," says NIAID director Anthony S. Fauci, M.D. "But the connection between the virus and expression of its own receptor on a cell is even more provocative because it might change the way we think about KSHV-associated diseases and their treatment."

Although less common in the United States now than early in the AIDS pandemic, Kaposi's sarcoma is still the most common cancer associated with HIV infection. Prior to the AIDS pandemic, it wa
'"/>

Contact: Jason Socrates Bardi
jbardi@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
6-Apr-2006


Page: 1 2 3

Related medicine news :

1. Landmark study finds adult Delawareans with disabilities in only fair to poor health
2. Landmark schizophrenia treatment study reveals that medication alone is not always effective
3. Landmark study of islet transplantation reveals potential benefits in uncontrolled type 1 diabetes
4. Landmark study on diabetic foot infection published
5. Landmark book commemorates centennial of discovery of Alzheimers disease
6. Landmark trial shows carotid stenting beneficial for patients with disease but no symptoms
7. Landmark hypertension study launches extensive physician and patient education program
8. Jefferson pharmacologist says biomarker discovery bodes well for better cancer diagnostics
9. Speeding fingertip discovery -- 20 years of protein info in 1 place
10. Major discovery raises prospect of better patient care by improving platelet life span
11. African scientists will train at Emory University in latest drug discovery techniques

Post Your Comments:
(Date:7/1/2015)... , ... July 01, 2015 , ... Amada Senior Care, ... new office in the greater Phoenix area – their Mesa, Arizona location . ... senior care with their purchase of the rights to the area after years of ...
(Date:7/1/2015)... ... ... Who doesn’t want a life filled with thriving positivity and high-life satisfaction? Do ... life, and positive friendships and relationships? , Dr. Marsha W. Snyder explains how ... , With a focus on solving the epidemic of ill-being in the medical profession, ...
(Date:7/1/2015)... ... July 01, 2015 , ... Northbound Treatment Services ... of Referral Relations. , Emily originally entered the behavioral healthcare industry as ... implemented unique academic curriculum for clients to engage in their educational journey while ...
(Date:7/1/2015)... ... July 01, 2015 , ... AvePoint, ... announced the opening of a new operational office in Zurich, Switzerland. The new ... across all lines of business for organizations throughout the Swiss market. , ...
(Date:7/1/2015)... ... 2015 , ... Recent research has revealed that most adults lack confidence in ... to professionals. Starting the last Monday of June, Whiter Image Dental will ... discount on the customer’s first popular In-Office 2 Patient Kit. , ...
Breaking Medicine News(10 mins):Health News:Amada Senior Care Expands to Greater Phoenix Area 2Health News:Medical Doctor Explains The Healthy Effects of a Positive Outlook in New Book 2Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 3Health News:Whiter Image Dental Offers New Customers Half-Off Teeth Whitening Kit 2
(Date:6/30/2015)... June 30, 2015  Inari Medical, Inc. announced today ... venture capital financing. The financing was led by members ... Ventures and US Venture Partners.  The round also included ... "We are very pleased to complete this financing with ... Bill Hoffman , who joined in February 2015 as ...
(Date:6/30/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... in the Company,s Phase IIb trial of its oral ... performed under the active Investigational New Drug (IND) application ... (FDA). The Phase IIb study for type ...
(Date:6/30/2015)... DUBLIN , June 24, 2015 ... addition of the "Global Endoscopy Devices Market ... The global endoscopy devices market to grow at ... The global endoscopy devices market can be ... and accessories, and services. The market can be ...
Breaking Medicine Technology:Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 3Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 3
Cached News: